August 2021 - LumaVive sponsors a small UV light EAE mouse model experiment to generate preliminary efficacy data for multiple sclerosis.
January 2022 - Application made to the NIH's NIAID for small business funding for pre-clinical research on UV light and EAE mouse model for multiple sclerosis.
February 2022 - LumaVive sponsors a small UV light CIA mouse model experiment to generate preliminary efficacy data for rheumatoid arthritis.
April 2022 - Application made to the NIH's NIAMS for small business funding for pre-clinical research on UV light and CIA mouse model for rheumatoid arthritis.
June 2022 - Application made to the US Department of Defense CDMRP program for a Multiple Sclerosis clinical trial to be done at the University of Alabama, Birmingham.
June 2022 - Application made to the National Multiple Sclerosis Sclerosis Society for pre-clinical research on UV light and the EAE mouse model.